The Rewards Of Planning Ahead: Designing For Full cGMP Production At Pilot Scale

By Dr. Nandu Deorkar Ph.D., MBA, Senior Vice President, Research & Development

Can very early adoption of cGMP-compliant raw materials help avoid additional costs, potential process re-development, and lost production time? Explore critical areas where up-front costs can be recouped by avoiding quality, compliance, supply, and logistics pitfalls when you scale. A seamless transition to commercialization is possible when you integrate high quality, multi-compendial reagents with a customized and holistic mAb manufacturing process, yielding substantial benefits to both productivity and patient safety.